AI, ANALYTICS AND AUTOMATION: NEW REALITIES OF PHARMA R&D | |
---|---|
10.30 – 11.30 | Registration |
11.30 – 11.40 | Welcome address |
11.40 – 12.00 | Keynote address |
12.00 – 13.00 | Cognitive technologies: Catalysing R&D productivity / Innovation through co-opetition: Panacea or a pipe dream? – Dr. Tathagata Dutta, Vice-President & Chief Scientific Officer (CSO), Jamp Pharma |
13.00 – 13.30 | Rise of R&D outsourcing – Dr. Rajendar Bandari, Associate Director, Slayback Pharma |
13.30 – 14.30 | Networking Lunch |
14.30 – 14.50 | GLP: Optimising R&D life cycle management – Anil K. Binnor, Associate Vice President, Head AR&D, Hetero Labs – Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo Pharma – Dr. Ramakrishna Bangaru, Sr. Vice-President, Mylan Laboratories |
14.50 – 15.50 | Digital technologies and their challenges, impact on standards and medicine quality assurance – Dr. Chaitanya Kumar Koduri, Associate Director, United States Pharmacopeia |
15.50 – 16.10 | Powering pharma R&D with computational & in-silico possibilities – Pushpa Vijayraghavan, Director, Sathguru Management Consultants |
16.10 – 16.30 | Patient-centric R&D: What does it entail? – Srinivasa Rao Bikkumalla, Associate Vice President & Head – Global Business Operations, Natco Pharma |
16.30 – 16.40 | Vote of thanks |
TECHNICAL SEMINAR ON PIONEERING JAPANESE INSPECTION TECHNOLOGY IN PHARMA INDUSTRY | |
17.00 – 17.30 | Welcome Note |
17.30 – 18.00 | Presentation by Hitachi, Japan – Time-tested novel approach to eliminate false rejects and increase high end product quality & yield Mr. Shinsuke Yamane, Hitachi Industry & Control Solutions., Ltd. |